Autolus Therapeutics plc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,898.5% | -1,399.0% | -401.5% | – | – | -130,806.9% | -841.3% | -347.9% | -320.4% | -277.6% | -249.1% | -54.9% | -192.2% | |
| 339.7% | 100.0% | 17.9% | – | – | 7,162.1% | 25.4% | 20.6% | 2.8% | 18.9% | 10.3% | 5.8% | 9.0% | |
| 704.4% | 184.5% | 22.6% | – | – | 21,493.1% | 31.9% | 20.5% | 18.1% | 14.2% | 13.6% | 10.1% | 13.2% | |
| 3,432.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2,640.6% | 1,173.7% | -136.3% | – | – | -10,296.6% | -197.0% | -109.5% | 191.7% | 4.3% | -62.8% | 15.1% | 27.4% | |
| 369.0% | 83.2% | 5.3% | – | – | 82,262.1% | 91.8% | 34.8% | 73.2% | 98.0% | 10.2% | 2.0% | 36.5% | |
| -369.0% | -83.2% | -5.3% | – | – | -1,322,720.7% | -663.0% | 458.4% | 167.7% | 356.8% | 366.7% | 148.6% | 243.8% | |
| 1.0% | 1.3% | 5,563.8% | – | – | 103,472.4% | 0.0% | -3.7% | -8.4% | -7.4% | -7.9% | -4.7% | -6.6% | |
| -12,557.4% | -930.4% | 5,145.3% | – | – | -1,481,834.5% | -1,464.6% | 134.2% | -177.9% | 74.3% | 102.2% | 88.6% | 40.5% | |
| -10,267.5% | -1,482.3% | -406.8% | – | – | -213,069.0% | -933.1% | -382.6% | -247.1% | -375.6% | -259.4% | -56.9% | -202.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.